Interferon-α Inducible Protein 6 Impairs EGFR Activation by CD81 and Inhibits Hepatitis C Virus Infection

Overview

Journal Sci Rep

Specialty Science

Date 2015 Mar 12

PMID 25757571

Citations 44

Authors

Keith Meyer

Young-Chan Kwon

Shuanghu Liu

Curt H Hagedorn

Ratna B Ray

Ranjit Ray

Affiliations

Soon will be listed here.

Abstract

Viral entry requires co-operative interactions of several host cell factors. Interferon (IFN) and the IFN-stimulated genes (ISGs) play a central role in antiviral responses against hepatitis C virus (HCV) infection. We examined the effect of interferon-α inducible protein 6 (IFI6) against HCV infection in human hepatoma cells. HCV RNA level or infectious foci were inhibited significantly by ectopic expression of IFI6. IFI6 impaired CD81 co-localization with claudin-1 (CLDN1) upon HCV infection or CD81 cross-linking by specific antibody. Activation of epidermal growth factor receptor (EGFR), a co-factor involved in CD81/CLDN1 interactions, was reduced in IFI6 expressing cells in response to HCV infection or CD81 cross linking by antibody, but not by treatment with EGF. Taken together, the results from our study support a model where IFI6 inhibits HCV entry by impairing EGFR mediated CD81/CLDN1 interactions. This may be relevant to other virus entry processes employing EGFR.

Citing Articles

Differential Inflammatory and Immune Response to Viral Infection in the Upper-Airway and Peripheral Blood of Mild COVID-19 Cases.

Gajate-Arenas M, Garcia-Perez O, Dominguez-de-Barros A, Sirvent-Blanco C, Dorta-Guerra R, Garcia-Ramos A J Pers Med. 2024; 14(11).

PMID: 39590591 PMC: 11595938. DOI: 10.3390/jpm14111099.

Multi-omics analysis reveals the impact of influenza a virus host adaptation on immune signatures in pig tracheal tissue.

Laybourn H, Hellemann Polhaus C, Kristensen C, Lyngfeldt Henriksen B, Zhang Y, Brogaard L Front Immunol. 2024; 15:1432743.

PMID: 39247193 PMC: 11378526. DOI: 10.3389/fimmu.2024.1432743.

Immunosuppression and phenotypic plasticity in an atlas of human hepatocholangiocarcinoma.

Li Y, Xun Z, Long J, Sun H, Yang X, Wang Y Hepatobiliary Surg Nutr. 2024; 13(4):586-603.

PMID: 39175731 PMC: 11336540. DOI: 10.21037/hbsn-23-400.

The Immune Response of , , and Genes in the Pathogenesis of COVID-19.

Gajate-Arenas M, Fricke-Galindo I, Garcia-Perez O, Dominguez-de-Barros A, Perez-Rubio G, Dorta-Guerra R Int J Mol Sci. 2024; 25(9).

PMID: 38731851 PMC: 11083791. DOI: 10.3390/ijms25094632.

CD81 suppresses NF-κB signaling and is downregulated in hepatitis C virus expressing cells.

Bunz M, Eisele M, Hu D, Ritter M, Kammerloher J, Lampl S Front Cell Infect Microbiol. 2024; 14:1338606.

PMID: 38357447 PMC: 10864554. DOI: 10.3389/fcimb.2024.1338606.

References

Parker N, Porter A . Identification of a novel gene family that includes the interferon-inducible human genes 6-16 and ISG12. BMC Genomics. 2004; 5(1):8. PMC: 343271. DOI: 10.1186/1471-2164-5-8. View

Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo B . Tight junction proteins. Prog Biophys Mol Biol. 2002; 81(1):1-44. DOI: 10.1016/s0079-6107(02)00037-8. View

Schoggins J, Dorner M, Feulner M, Imanaka N, Murphy M, Ploss A . Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proc Natl Acad Sci U S A. 2012; 109(36):14610-5. PMC: 3437900. DOI: 10.1073/pnas.1212379109. View

Kubicek M, Pacher M, Abraham D, Podar K, Eulitz M, Baccarini M . Dephosphorylation of Ser-259 regulates Raf-1 membrane association. J Biol Chem. 2002; 277(10):7913-9. DOI: 10.1074/jbc.M108733200. View

Itsui Y, Sakamoto N, Kurosaki M, Kanazawa N, Tanabe Y, Koyama T . Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. J Viral Hepat. 2006; 13(10):690-700. DOI: 10.1111/j.1365-2893.2006.00732.x. View

Li J, Ding S, Cho H, Chung B, Gale Jr M, Chanda S . A short hairpin RNA screen of interferon-stimulated genes identifies a novel negative regulator of the cellular antiviral response. mBio. 2013; 4(3):e00385-13. PMC: 3684836. DOI: 10.1128/mBio.00385-13. View

Basu A, Kanda T, Beyene A, Saito K, Meyer K, Ray R . Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells. J Virol. 2007; 81(8):3933-41. PMC: 1866147. DOI: 10.1128/JVI.02622-06. View

Ploss A, Evans M, Gaysinskaya V, Panis M, You H, de Jong Y . Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature. 2009; 457(7231):882-6. PMC: 2762424. DOI: 10.1038/nature07684. View

Zang M, Gong J, Luo L, Zhou J, Xiang X, Huang W . Characterization of Ser338 phosphorylation for Raf-1 activation. J Biol Chem. 2008; 283(46):31429-37. PMC: 2581588. DOI: 10.1074/jbc.M802855200. View

10.

Zona L, Lupberger J, Sidahmed-Adrar N, Thumann C, Harris H, Barnes A . HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex. Cell Host Microbe. 2013; 13(3):302-13. DOI: 10.1016/j.chom.2013.02.006. View

11.

Scarselli E, Ansuini H, Cerino R, Roccasecca R, Acali S, Filocamo G . The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 2002; 21(19):5017-25. PMC: 129051. DOI: 10.1093/emboj/cdf529. View

12.

Liu S, Sanchez D, Cheng G . New developments in the induction and antiviral effectors of type I interferon. Curr Opin Immunol. 2010; 23(1):57-64. PMC: 3822007. DOI: 10.1016/j.coi.2010.11.003. View

13.

Gjermandsen I, Justesen J, Martensen P . The interferon-induced gene ISG12 is regulated by various cytokines as the gene 6-16 in human cell lines. Cytokine. 2000; 12(3):233-8. DOI: 10.1006/cyto.1999.0549. View

14.

Wilkins C, Woodward J, Lau D, Barnes A, Joyce M, McFarlane N . IFITM1 is a tight junction protein that inhibits hepatitis C virus entry. Hepatology. 2012; 57(2):461-9. PMC: 3566288. DOI: 10.1002/hep.26066. View

15.

Hanahan D, Weinberg R . The hallmarks of cancer. Cell. 2000; 100(1):57-70. DOI: 10.1016/s0092-8674(00)81683-9. View

16.

Daum G, Fries H, Troppmair J, Rapp U . The ins and outs of Raf kinases. Trends Biochem Sci. 1994; 19(11):474-80. DOI: 10.1016/0968-0004(94)90133-3. View

17.

Kanda T, Basu A, Steele R, Wakita T, Ryerse J, Ray R . Generation of infectious hepatitis C virus in immortalized human hepatocytes. J Virol. 2006; 80(9):4633-9. PMC: 1472020. DOI: 10.1128/JVI.80.9.4633-4639.2006. View

18.

Basuroy S, Sheth P, Kuppuswamy D, Balasubramanian S, Ray R, Rao R . Expression of kinase-inactive c-Src delays oxidative stress-induced disassembly and accelerates calcium-mediated reassembly of tight junctions in the Caco-2 cell monolayer. J Biol Chem. 2003; 278(14):11916-24. DOI: 10.1074/jbc.M211710200. View

19.

Raychoudhuri A, Shrivastava S, Steele R, Kim H, Ray R, Ray R . ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J Virol. 2011; 85(24):12881-9. PMC: 3233139. DOI: 10.1128/JVI.05633-11. View

20.

Zhang J, Randall G, Higginbottom A, Monk P, Rice C, McKeating J . CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Virol. 2004; 78(3):1448-55. PMC: 321402. DOI: 10.1128/jvi.78.3.1448-1455.2004. View